Have questions?

Purigen Biosystems, Inc.

REQUEST DEMO
Nucleic Acid Purification – Pure and Simple

About Purigen Biosystems

Purigen Biosystems' transformative Ionic Purification System provides a hands-free solution for extracting, enriching and quantifying DNA and RNA from biological samples. Our proprietary approach uses isotachophoresis (ITP), an electric-field-driven technique for purifying, focusing, and/or separating species. The application of ITP to purify and quantify nucleic acids from complex biological samples was pioneered by Purigen co-founder, Stanford Professor Juan G. Santiago. The Ionic® Purification System is compatible with a range of samples including cells and FFPE.

Leadership Team

  • Klint Rose, Ph.D.
    CSO and Co-founder
    READ BIO >

    Klint Rose, Ph.D.

    CSO and Co-founder

    Dr. Klint Rose co-founded Purigen Biosystems in 2012. Dr. Rose was previously an R&D Manager at QuantaLife, Inc. (acquired by Bio-Rad), where he played a key leadership role in the development, launch, and support of their droplet digital PCRTM product. He previously directed a portfolio of several successful projects at Lawrence Livermore National Laboratory (LLNL) with applications in sample preparation, desalination, and nanomanufacturing. Dr. Rose is an expert in microfluidics and electrokinetics, with over 15 years of experience in the space. Klint received his B.S. and M.S. in mechanical engineering from the Massachusetts Institute of Technology (MIT) and his Ph.D. from Stanford University.
  • Chris Grimley
    Chief Commercial Officer
    READ BIO >

    Chris Grimley

    Chief Commercial Officer

    Chris Grimley brings over 25 years of experience in the life science industry to his role at Purigen. Prior to joining Purigen Mr. Grimley was Vice President of Marketing at Labcyte Inc. (acquired by Beckman Life Sciences), and prior to that Vice President of Marketing at NanoString Technologies during which time the company completed its IPO. Mr. Grimley has also served as Senior Director of Marketing at Agilent Technologies, managing the company’s genomics portfolio which included microarray, target enrichment and molecular biology reagents product lines. Mr. Grimley began his career at Applied Biosystems (now part of Thermo Fisher Scientific) where he held positions of increasing responsibility including Director of Marketing for the company’s real-time PCR instrument portfolio. Mr. Grimley holds a Bachelor of Science degree in Biochemistry from San Francisco State University.